VAGHI, GLORIA
 Distribuzione geografica
Continente #
NA - Nord America 635
AS - Asia 552
EU - Europa 418
SA - Sud America 98
AF - Africa 32
Totale 1.735
Nazione #
US - Stati Uniti d'America 616
SG - Singapore 168
CN - Cina 146
VN - Vietnam 85
RU - Federazione Russa 82
BR - Brasile 77
HK - Hong Kong 72
DE - Germania 65
IE - Irlanda 64
IT - Italia 59
FR - Francia 38
GB - Regno Unito 32
FI - Finlandia 28
IN - India 22
ZA - Sudafrica 19
BD - Bangladesh 12
AT - Austria 9
JP - Giappone 9
CA - Canada 8
MX - Messico 8
IQ - Iraq 7
PL - Polonia 7
ES - Italia 6
NL - Olanda 6
CO - Colombia 5
ID - Indonesia 5
AR - Argentina 4
CZ - Repubblica Ceca 4
MA - Marocco 4
SE - Svezia 4
CH - Svizzera 3
EC - Ecuador 3
PK - Pakistan 3
TN - Tunisia 3
TR - Turchia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
CL - Cile 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
PE - Perù 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 1.735
Città #
Singapore 97
Ashburn 82
San Jose 78
Hong Kong 70
Dallas 68
Dublin 64
Beijing 54
Chandler 51
Los Angeles 36
Munich 27
Lauterbourg 23
Hanoi 20
Ho Chi Minh City 20
Milan 19
Boardman 18
Johannesburg 18
Helsinki 16
Moscow 14
New York 13
Shanghai 13
Frankfurt am Main 12
São Paulo 12
Turku 12
London 10
Redondo Beach 10
Brooklyn 9
Buffalo 9
Tokyo 9
Rome 8
Santa Clara 8
Düsseldorf 7
Orem 7
Warsaw 7
Falkenstein 6
Lawrence 6
Medford 6
Mexico City 6
Princeton 6
The Dalles 6
Boston 5
Chennai 5
Da Nang 5
Atlanta 4
Belo Horizonte 4
Cuiabá 4
Dhaka 4
Medellín 4
Nuremberg 4
Phoenix 4
Poplar 4
Stockholm 4
Amsterdam 3
Chicago 3
Columbus 3
Cremona 3
Denver 3
Hefei 3
Hyderabad 3
Manchester 3
Mumbai 3
Ninh Bình 3
Piscataway 3
Portsmouth 3
Secaucus 3
Serra 3
Seveso 3
Toronto 3
Vienna 3
Wilmington 3
Amman 2
Ankara 2
Athens 2
Baghdad 2
Bishkek 2
Bologna 2
Brasília 2
Campinas 2
Chandigarh 2
Changsha 2
City of London 2
Cormano 2
Denpasar 2
Dongguan 2
Edinburgh 2
Elk Grove Village 2
Fortaleza 2
Guangzhou 2
Guayaquil 2
Ha Long 2
Haiphong 2
La Tronche 2
Lahore 2
Lima 2
Manama 2
Olomouc 2
Pune 2
Riga 2
Rio de Janeiro 2
Santiago 2
Tashkent 2
Totale 1.124
Nome #
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 123
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 100
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 99
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 96
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 92
Potential Contribution of Hypertension to Evolution of Chronic Migraine and Related Mechanisms 91
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression 86
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 85
BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in the CLINICAL PICTURE of DEMENTIA 83
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 80
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 76
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 74
High-frequency episodic migraine: Time for its recognition as a migraine subtype? 68
Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview 66
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 64
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 61
Pearls & Oy-sters: Marionette Walk in Parkinson Disease 58
Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis 55
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 54
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 52
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches 50
Redefining migraine prevention: Early treatment with anti-CGRP monoclonal antibodies enhances response in the real world 50
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 50
Who cares about migraine? Pathways and hurdles in the European region - access to care III 37
Clinical and instrumental gait phenotyping in people with GLUT-1 deficiency syndrome 27
null 11
Totale 1.788
Categoria #
all - tutte 7.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 1 0 2
2021/202221 0 0 0 0 0 0 0 3 1 3 1 13
2022/2023151 13 11 0 10 13 11 2 13 68 3 6 1
2023/202494 7 10 2 1 8 12 2 15 1 6 14 16
2024/2025513 11 13 9 2 11 71 55 28 120 34 68 91
2025/2026988 95 57 99 123 154 37 172 66 122 63 0 0
Totale 1.788